World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
59
Citations
12130
World Ranking
3431
National Ranking
1594

Nancy L. Haigwood publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Nancy L. Haigwood sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 188 publications — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Nancy L. Haigwood D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Nancy L. Haigwood sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 59 D-Index — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Nancy L. Haigwood is affiliated with Oregon Health & Science University in the United States. Their research primarily focuses on immunology and microbiology, with significant contributions to medicine. Their work spans several subfields including immunology, virology, infectious diseases, epidemiology, and radiology, nuclear medicine, and imaging.

The main topics addressed by their research include:

  • HIV Research and Treatment
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • HIV/AIDS Research and Interventions
  • Monoclonal and Polyclonal Antibodies Research
  • SARS-CoV-2 and COVID-19 Research
  • Cytomegalovirus and herpesvirus research

They have published extensively in various scientific venues. The most frequent publication venues include:

  • Nature Communications
  • The Journal of Immunology
  • Frontiers in Immunology
  • Vaccine
  • Journal of Virology

Some of the recent papers authored or co-authored by Nancy L. Haigwood are:

  • "Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunity," 2020, Nature Communications
  • "Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic," 2021, Frontiers in Public Health
  • "ACTIVating Resources for the COVID-19 Pandemic: In Vivo Models for Vaccines and Therapeutics," 2020, Cell Host & Microbe
  • "Phagocytosis by an HIV antibody is associated with reduced viremia irrespective of enhanced complement lysis," 2022, Nature Communications
  • "Antibody-based CCR5 blockade protects Macaques from mucosal SHIV transmission," 2021, Nature Communications

Their frequent co-authors include:

  • Ann J. Hessell
  • Shilpi Pandey
  • Philip Barnette
  • David A. Spencer
  • Jonah B. Sacha

The scientific contributions of Nancy L. Haigwood lie at the intersection of immunology, infectious disease, and therapeutic intervention research, with a strong emphasis on HIV/AIDS and emerging viral pathogens such as SARS-CoV-2.

Best Publications

  • Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis

    Nirmal K. Banda;Jacques Bernier;David K. Kurahara;Roland Kurrle

  • Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

    Riri Shibata;Tatsuhiko Igarashi;Nancy Haigwood;Alicia Buckler-White

  • Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin.

    Ming Zhang;Brian Gaschen;Wendy Blay;Wendy Blay;Brian Foley

  • Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells

    Barbara S. Chapman;Richard M. Thayer;Karen A. Vincent;Nancy L. Haigwood

  • Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to Gp120.

    Kathelyn S. Steimer;Carl J. Scandella;Paul V. Skiles;Nancy L. Haigwood

  • Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries

    Carlos F. Barbas;Thomas A. Collet;Willi Amberg;Paul Roben

  • Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines.

    John R. Mascola;Patricia D'Souza;Peter Gilbert;Beatrice H. Hahn

  • PLASMA VIREMIA IN MACAQUES INFECTED WITH SIMIAN IMMUNODEFICIENCY VIRUS : PLASMA VIRAL LOAD EARLY IN INFECTION PREDICTS SURVIVAL

    Andrew Watson;Jane Ranchalis;Bruce Travis;Janela McClure

  • Determination of a Statistically Valid Neutralization Titer in Plasma That Confers Protection against Simian-Human Immunodeficiency Virus Challenge following Passive Transfer of High-Titered Neutralizing Antibodies

    Yoshiaki Nishimura;Tatsuhiko Igarashi;Nancy Haigwood;Reza Sadjadpour

  • Hiv-i polynucleotide

    Philip J Barr;Dino Dina;Carlos George-Nascimento;Rob Hallenwell

  • Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell–free virions from blood plasma

    Tatsuhiko Igarashi;Charles Brown;Ali Azadegan;Nancy Haigwood

  • Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques

    Ann J Hessell;Ann J Hessell;J Pablo Jaworski;Erin Epson;Kenta Matsuda

  • DNA sequence organization of the β-globin complex in the BALB/c mouse

    Carolyn L. Jahn;Clyde A. Hutchison;Sandra J. Phillips;Steven Weaver

  • Human immunodeficiency virus type 1 subtype B ancestral envelope protein is functional and elicits neutralizing antibodies in rabbits similar to those elicited by a circulating subtype B envelope.

    N. A. Doria-Rose;G. H. Learn;A. G. Rodrigo;D. C. Nickle

  • Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile

    Nancy L. Haigwood;Andrew Watson;William F. Sutton;Jan McClure

  • Human natural killer cells mediate adaptive immunity to viral antigens.

    Rana Nikzad;Rana Nikzad;Laura S. Angelo;Kevin Aviles-Padilla;Duy T. Le

  • Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques

    Cherie T Ng;J Pablo Jaworski;Pushpa Jayaraman;Pushpa Jayaraman;Pushpa Jayaraman;William F Sutton

  • Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons.

    N L Haigwood;P L Nara;E Brooks;G A Van Nest

  • DNA vaccine strategies: candidates for immune modulation and immunization regimens.

    Nicole A. Doria-Rose;Nancy L. Haigwood

  • Use of broadly neutralizing antibodies for HIV-1 prevention

    Amarendra Pegu;Ann J. Hessell;John R. Mascola;Nancy L. Haigwood

Frequent Co-Authors

David C. Montefiori
David C. Montefiori Duke University
Jonah B. Sacha
Jonah B. Sacha Oregon Health & Science University
Leonidas Stamatatos
Leonidas Stamatatos Fred Hutchinson Cancer Research Center
Barbra A. Richardson
Barbra A. Richardson University of Washington
Vanessa M. Hirsch
Vanessa M. Hirsch National Institute of Allergy and Infectious Diseases
Marta L. Marthas
Marta L. Marthas University of California, Davis
Dennis R. Burton
Dennis R. Burton Scripps Research Institute
John R. Mascola
John R. Mascola ModeX Therapeutics
Philip R. Johnson
Philip R. Johnson Children's Hospital of Philadelphia
Susan Zolla-Pazner
Susan Zolla-Pazner Icahn School of Medicine at Mount Sinai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in studying Immunology in the USA, exploring related healthcare degrees can broaden career opportunities. Many students transition into nursing pathways, where understanding immunological concepts enhances patient care. Programs like the accelerated FNP program offer fast-tracked pathways for becoming a Family Nurse Practitioner, integrating advanced immunology knowledge.

If you’re new to healthcare, the best online RN programs for non nurses provide flexible options to enter nursing. These programs often include immunology coursework relevant to clinical settings, giving a strong scientific foundation.

For students seeking quicker entry into nursing roles, identifying the easiest ABSN to get into can be a practical choice. These programs typically have more accessible admission criteria, allowing students with diverse backgrounds to build their healthcare careers effectively.

Additionally, LPN programs with easiest admission requirements provide an entry point for those looking to quickly join the nursing workforce while gaining essential clinical skills, including basics in immune system function.

Understanding these related educational paths can help aspiring immunologists and healthcare professionals navigate their careers with informed decision-making.

Best Scientists Citing Nancy L. Haigwood

Trending Scientists

Recently Published Articles